• In conjunction with The Cornea Society

    Seeing Clearly Into the Future

    Saturday, Nov. 14
    Sands Expo/Venetian, Las Vegas

    Program Directors

    Sanjay V. Patel, MD, FRCOphth; Sophie X. Deng, MD, PhD and Vishal Jhanji MD

    Program Planning Group

    Sanjay V. Patel, MD, FRCOphth; Sophie X. Deng, MD, PhD and Vishal Jhanji MD

    Mission Statement

    The 2020 Cornea Subspecialty Day will provide cornea specialists and comprehensive ophthalmologists with new information and paradigms about diseases of the cornea and ocular surface to enable them to manage common and complex conditions using an evidence-based approach.

    Target Audience

    This program is for cornea specialists and surgeons, comprehensive ophthalmologists with an interest in anterior segment diseases, and allied health personnel who are involved in the medical and surgical care of patients with cornea and ocular surface diseases.

    Education Level

    Intermediate, Advanced


    The goals of this program are to:

    • Impart the latest recommendations for diagnosing common and complex corneal and ocular surface disease, including the use of imaging and laboratory testing
    • Discuss new evidence-based knowledge for medical and surgical therapeutic strategies for managing common and complex corneal and ocular surface disease.
    • Inform attendees about the complications and prognoses associated with common and complex corneal and ocular surface diseases.
    • Provide attendees with sufficient information to implement new knowledge and technology into clinical practice.

    Program Objectives

    Upon completion of this activity, participants should be able to:

    • Interpret imaging to assist in the diagnosis and management of corneal ectasia and Fuchs dystrophy, and apply evidence-based guidelines for the medical and surgical management of these conditions.
    • Recognize ocular surface disorders that warrant surgical intervention and determine the ideal approach and timing of intervention.
    • Articulate and apply current best practices for the management of corneal infections and ocular surface inflammatory diseases.
    • Discuss the role of keratoplasty and alternative treatments in the management of patients with corneal disease.

    CME Accreditation

    The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The American Academy of Ophthalmology designates this live activity for a maximum of 7 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Attendees registered as exhibitors, spouses or guests are not eligible for CME credits.

    Find more information about CME.